期刊文献+

糖基化终产物对人血管内皮细胞过氧化体增殖物激活型受体γ基因表达的影响

Effects of Advanced Glycation End-products on Expression of Peroxisome Proliferator Activated Receptor-γ mRNA in Cultured Human Vascular Endothelial Cells
下载PDF
导出
摘要 为探讨糖基化终产物对人血管内皮细胞表达过氧化体增殖物激活型受体γ基因的影响 ,体外培养人血管内皮细胞株 (ECV30 4 ) ,分别用不同浓度葡萄糖 (0、2 0、5 0和 80mmol L)孵育的糖基化终产物修饰牛血清白蛋白(2 0 0mg L)、不同浓度的糖基化终产物修饰牛血清白蛋白 (5 0、10 0、2 0 0和 4 0 0mg L)干预 2 4h和葡萄糖浓度为 5 0mmol L孵育的糖基化终产物修饰牛血清白蛋白干预细胞 0、12、2 4、36、4 8和 72h ,逆转录聚合酶链反应检测细胞中过氧化体增殖物激活型受体γmRNA的表达水平。结果发现 ,葡萄糖浓度为 2 0、5 0和 80mmol L孵育的糖基化终产物修饰牛血清白蛋白及浓度为 5 0、10 0、2 0 0和 4 0 0mg L的糖基化终产物修饰牛血清白蛋白都减少过氧化体增殖物激活型受体γmRNA的表达 (P <0 .0 0 1) ,干预 12、2 4、36、4 8和 72h后过氧化体增殖物激活型受体γmRNA表达均较未干预组明显减少 (P <0 .0 0 1)。此结果提示 ,糖基化终产物可抑制人血管内皮细胞过氧化体增殖物激活型受体γ基因的表达。 Aim To investigate mechanism for accelerated atherosclerosis in diabetic patients, effect of advanced glycosylation end-product (AGE) on the expression of peroxisome proliferator-activated receptor-γ (PPAR γ) mRNA was observed in cultured human vascular endothelial cells (ECV304). Methods The ECV304 cells were exposed to AGE-modified bovine serum albumin (AGE-BSA) of 200 mg/L (glycated with glucose of 0, 20, 50, 80 mmol/L) for 24 h, or incubated with AGE-BSA (50 mmol/L, 200 mg/L) for 0, 12, 24, 36, 48, 72 h, and were treated by AGE-BSA (50, 100, 200, 400 mg/L) for 24 h. Expression of PPARγ mRNA in ECV304 cells was measured by RT-PCR with β-actin as internal standard. Results The expressions of PPARγ mRNA were decreased by AGE-BSA incubated with glucose concentration of 20, 50, 80 mmol/L (P<0.001) and depressed by AGE-BSA (50, 100, 200, 400 mg/L), respectively. After intervention of AGE-BSA for periods of 12, 24, 36, 48, 72 h, PPARγ mRNA expression was decreased markedly (P<0.001). Conclusion AGE-BSA could decrease the expression of PPARγ mRNA in cultured human vascular endothelial cells, which might be partly involved in atherogenesis in diabetic patients.
作者 刘勇 刘乃丰
出处 《中国动脉硬化杂志》 CAS CSCD 2004年第2期135-138,共4页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金 ( 3 0 0 70 3 0 0 )资助
关键词 细胞生物学 糖尿病 糖基化终产物 人血管肉皮细胞 过氧化体增殖物激活型受体Γ 基因表达 Cellular Biology Diabetes Glycation End Products,Advanced Human Vascular Endothelial Cells Peroxisome Proliferator Activated Receptor-γ Gene Expression
  • 相关文献

参考文献17

  • 1余路,邱鸿鑫,陈文缘,戎健,陈婉蓉,祝继华,粟绍初,李萍.糖尿病大鼠糖基化终产物与主动脉细胞外基质成分的关系[J].中国动脉硬化杂志,1999,7(4):311-314. 被引量:7
  • 2严金川,刘乃丰.维生素E对糖基化终产物刺激大鼠主动脉平滑肌细胞信号转导物甘油二酯的影响[J].中国动脉硬化杂志,1999,7(1):54-56. 被引量:3
  • 3Tontonoz P,Nagy L,Alvarez JGA,Thomazy VA,Evans RM.PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL.Cell,1998,93 (2):241-252
  • 4Levi Z,Shaish A,Yacov N,Levkovitz H,Trestman S,Gerber Y,et al.Rosiglitazone (PPARgamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model.Diabetes Obes Metab,2003,5 (1):45-48
  • 5Minamikawa J,Tanaka S,Yamauchi M,Inoue D,Koshiyama H.Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes.J Clin Endocrinol Metab,1998,83(5):1 818-820
  • 6Thieringer R,Fenyk-Melody JE,Le Grand CB,Shelton BA,Detmers PA,Somers EP,et al.Activation of peroxisome proliferator-activated receptor-γ does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo.J Immunol,2000,164 (2):1 046-054
  • 7Izumi S,Hirai K,Miyamasu M,Takahashi Y,Misaki Y,Takaishi T,et al.Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils.Eur J Immunol,1997,27 (4):816-824
  • 8Sakata N,Imanaga Y,Meng J,Tachikawa Y,Takebayashi S,Nagai R,et al.Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.Atherosclerosis,1998,141 (1):61-75
  • 9Kume S,Takeya M,Mori T,Araki N,Suzuki H,Horiuchi S,et al.Immunohistochemical and ultrastructural detection of advanced glycation end produ ts in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.Am J Pathol,1995,147 (3):654-667
  • 10孙子林,刘乃丰,孙桂菊,童嘉毅,王伯荣,刘必成.糖尿病小鼠血清糖基化终产物水平增高[J].中国糖尿病杂志,2000,8(5):315-315. 被引量:7

二级参考文献27

  • 1[1]Miyata T, van Yperele de Strihou C, Kurokawa K, et al. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int, 1999, 55 (2): 389-399
  • 2[2]Campbell JC, Campbell GR, Ross R. The smooth muscle cells in culture.Physiol Rew, 1979, 59:1-61
  • 3[3]Wumin Dong, Petia P simeonova, Randle Gallucci, et al. Cytokine expression in hepatocytes: Role of oxidant stress. J Interf Cytok Res, 1998, 18:629-638
  • 4[4]Sakata N, Imanaga Y, Meng J, et al. Immunohistochemical localization of different epitopes of advanced glycosylation end products in human atherosclerotic lesions. Atherosclerosis, 1998, 144 (1): 61-75
  • 5[5]Helen V. Recent progress in advanced glycosylation end products and diabetic complications. Diabetes, 1997, 46 (suppl): s19-s25
  • 6[6]Ruan Q, Deng Z, Song J. Very low-density lipoprotein and oxidized very low density lipoprotein induce monocyte chemotactic protein-1 in rabbit aortic smooth musclecells. Chin Med J Engl, 1996, 109(3): 206-209
  • 7[7]Porreca E, Di Febbo C, Reale M, et al. Monocyte chemotactic protein-1(MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. J Vasc Res, 1997, 34 (1): 58-65
  • 8[8]Scheeter AD, Rollins BJ, Zhang YJ, et al. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells.JBiol C heem, 1997, 272 (45): 28 568-573
  • 9[1]Barger PM, Kelly DP. Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. Am J Med Sci, 1999, 318:36-42
  • 10[2]Binas B, Danneberg H, McWhir J, Minllins L, Clark AJ. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J, 1999, 13:805-812

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部